Retrospective analysis of treatment-naive Slovenian patients with metastatic melanoma treated with pembrolizumab – real-world experience
Hribernik, Nezka, Boc, Marko, Ocvirk, Janja, Knez-Arbeiter, Jasna, Mesti, Tanja, Ignjatovic, Marija, Rebersek, Martina
Adverse events during immunotherapy in Slovenian patients with metastatic melanoma reveal a positive correlation with better treatment outcomes
Mesti, Tanja, Ceplak Mencin, Vid, Mileva Boshkoska, Biljana, Ocvirk, Janja
Bevacizumab plus chemotherapy in elderly patients with previously untreated metastatic colorectal cancer: single center experience
Ocvirk, Janja, Moltara, Maja Ebert, Mesti, Tanja, Boc, Marko, Rebersek, Martina, Volk, Neva, Benedik, Jernej, Hlebanja, Zvezdana
Prognostic factors for overall survival and safety of trans-arterial chemoembolization (TACE) with irinotecan-loaded drug-eluting beads (DEBIRI) in patients with colorectal liver metastases
Sljivic, Maja, Sever, Masa, Ocvirk, Janja, Mesti, Tanja, Brecelj, Erik, Popovic, Peter
Molecular biomarkers and histological parameters impact on survival and response to first- line systemic therapy of metastatic colorectal cancer patients
Rebersek, Martina, Mesti, Tanja, Boc, Marko, Ocvirk, Janja
The cost of systemic therapy for metastatic colorectal carcinoma in Slovenia: discrepancy analysis between cost and reimbursement
Mesti, Tanja, Boshkoska, Biljana Mileva, Kos, Mitja, Tekavčič, Metka, Ocvirk, Janja
Malignant gliomas: old and new systemic treatment approaches
Mesti, Tanja, Ocvirk, Janja
Digital ischemic events related to gemcitabine: Report of two cases and a systematic review
Kuhar, Cvetka, Mesti, Tanja, Zakotnik, Branko
Bevacizumab and irinotecan in recurrent malignant glioma, a single institution experience
Mesti, Tanja, Ebert Moltara, Maja, Boc, Marko, Rebersek, Martina, Ocvirk, Janja
Nuclear magnetic resonance metabolic fingerprint of bevacizumab in mutant IDH1 glioma cells
Mesti, Tanja, Bouchemal, Nadia, Banissi, Claire, Triba, Mohamed N., Marbeuf-Gueye, Carole, Cemazar, Maja, Moyec, Laurence Le, Carpentier, Antoine F., Savarin, Philippe, Ocvirk, Janja
The five-year KRAS, NRAS and BRAF analysis results and treatment patterns in daily clinical practice in Slovenia in 1st line treatment of metastatic colorectal (mCRC) patients with RAS wild-type tumour (wtRAS) – a real- life data report 2013–2018
Mesti, Tanja, Rebersek, Martina, Ocvirk, Janja